Sp422
THE INNOVATION CYCLE: GOING BEYOND RESEARCH TO INNOVATION AND COMMERCIALIZATION
Date
May 19, 2024
Presenter
Northwestern University
Tracks
Related Products
DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING (ML) BASED DECISION-MAKING TOOL TO DETERMINE RISK AND TIMING OF RECURRENCE OF BARRETT’S ESOPHAGUS (BE) NEOPLASIA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET)
Recent studies have described the durability of EET for BE-related neoplasia and the risk of neoplastic recurrence after achieving complete eradication of intestinal metaplasia (CE-IM). Current guidelines for endoscopic surveillance intervals post-EET are based on limited evidence…
LOW INCIDENCE OF RECURRENT NEOPLASTIC BARRETT’S ESOPHAGUS (BE) AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET): LONG-TERM OUTCOMES FROM A MULTICENTER PROSPECTIVE COHORT STUDY
INTRODUCTION: EET is endorsed by guidelines for treatment of BE-related neoplasia patients. Few studies describe long-term durability outcomes in BE patients who achieve complete eradication of intestinal metaplasia (CE-IM) following EET…
LEVERAGING ARTIFICIAL INTELLIGENCE IN GASTROENTEROLOGY RESEARCH: THE TRANSFORMATIVE ROLE OF PROMPT ENGINEERING IN MAKING MANUAL DATA ABSTRACTION OBSOLETE
Recent advancements in artificial intelligence (AI) have transformed the landscape of health care, through innovative technologies that improve clinical decision making and patient outcomes…
